Cardinal Health, Inc. $CAH Shares Sold by Man Group plc

Man Group plc decreased its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 36.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,020,795 shares of the company’s stock after selling 584,554 shares during the quarter. Man Group plc owned approximately 0.43% of Cardinal Health worth $209,773,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of CAH. Norges Bank purchased a new stake in Cardinal Health during the 4th quarter worth about $790,344,000. Wellington Management Group LLP raised its holdings in Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after acquiring an additional 3,511,579 shares in the last quarter. Holocene Advisors LP raised its holdings in Cardinal Health by 141.4% in the third quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock valued at $302,332,000 after acquiring an additional 1,128,358 shares in the last quarter. Marshall Wace LLP raised its holdings in Cardinal Health by 1,328.1% in the fourth quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock valued at $195,484,000 after acquiring an additional 884,648 shares in the last quarter. Finally, Barclays PLC raised its holdings in Cardinal Health by 109.3% in the third quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock valued at $248,658,000 after acquiring an additional 827,446 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.6%

Cardinal Health stock opened at $226.29 on Thursday. The stock has a market cap of $53.00 billion, a PE ratio of 34.60, a P/E/G ratio of 1.25 and a beta of 0.52. The stock has a 50-day moving average price of $204.01 and a 200 day moving average price of $209.11. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $233.60.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the business posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is presently 31.19%.

Analyst Ratings Changes

CAH has been the topic of several analyst reports. Evercore reduced their target price on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a report on Wednesday, April 8th. JPMorgan Chase & Co. reduced their target price on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a report on Monday, May 4th. Morgan Stanley raised their target price on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a report on Tuesday, April 28th. TD Cowen lifted their price target on Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. Finally, Citigroup cut their price target on Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a research note on Friday, May 1st. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and a consensus price target of $246.93.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.